Abstract
Whole-genome and centrosome duplication as a consequence of cytokinesis failure can drive tumorigenesis in experimental model systems. However, whether cytokinesis failure is in fact an important cause of human cancers has remained unclear. In this Review, we summarize evidence that whole-genome-doubling events are frequently observed in human cancers and discuss the contribution that cytokinesis defects can make to tumorigenesis. We provide an overview of the potential causes of cytokinesis failure and discuss how tetraploid cells that are generated through cytokinesis defects are used in cancer as a transitory state on the route to aneuploidy. Finally, we discuss how cytokinesis defects can facilitate genetic diversification within the tumour to promote cancer development and could constitute the path of least resistance in tumour evolution.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Glotzer, M. Cytokinesis in metazoa and fungi. Cold Spring Harb. Perspect. Biol. 9, a022343 (2017).
Green, R. A., Paluch, E. & Oegema, K. Cytokinesis in animal cells. Annu. Rev. Cell Dev. Biol. 28, 29–58 (2012).
Duijf, P. H., Schultz, N. & Benezra, R. Cancer cells preferentially lose small chromosomes. Int. J. Cancer 132, 2316–2326 (2013).
Weaver, B. A. & Cleveland, D. W. Aneuploidy: instigator and inhibitor of tumorigenesis. Cancer Res. 67, 10103–10105 (2007).
Bielski, C. M. et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat. Genet. 50, 1189–1195 (2018). This paper sequences a large number of primary tumours to demonstrate that genome-doubling events are very common in human cancer.
Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413–421 (2012).
de Bruin, E. C. et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346, 251–256 (2014). This study nicely describes the genome evolution of lung cancer as determined by deep sequencing and demonstrates that subclonal diversification is driven by heterogeneous genetic instability.
Galipeau, P. C. et al. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett’s esophagus. Proc. Natl Acad. Sci. USA 93, 7081–7084 (1996). This is a landmark study into Barrett oesophagus that provides compelling evidence for tetraploidy as an early event in tumorigenesis.
Imkie, M., Davis, M. K., Persons, D. L. & Cunningham, M. T. Biphasic acute myeloid leukemia with near-tetraploidy and immunophenotypic transformation. Arch. Pathol. Lab. Med. 128, 448–451 (2004).
Olaharski, A. J. et al. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 27, 337–343 (2006).
Shackney, S. E. et al. Model for the genetic evolution of human solid tumors. Cancer Res. 49, 3344–3354 (1989).
Storchova, Z. & Kuffer, C. The consequences of tetraploidy and aneuploidy. J. Cell Sci. 121, 3859–3866 (2008).
Taylor, A. M. et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33, 676–689 (2018).
Watanabe, A. et al. Near-triploidy and near-tetraploidy in hematological malignancies and mutation of the p53 gene. Clin. Lab. Haematol. 26, 25–30 (2004).
Zack, T. I. et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45, 1134–1140 (2013).
Duelli, D. M. et al. A virus causes cancer by inducing massive chromosomal instability through cell fusion. Curr. Biol. 17, 431–437 (2007).
Fujiwara, T. et al. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437, 1043–1047 (2005). This study provides the first direct evidence that cytokinesis failure promotes tumorigenesis.
Ganem, N. J., Godinho, S. A. & Pellman, D. A mechanism linking extra centrosomes to chromosomal instability. Nature 460, 278–282 (2009).
Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643–649 (1998).
Nguyen, H. G. et al. Deregulated Aurora-B induced tetraploidy promotes tumorigenesis. FASEB J. 23, 2741–2748 (2009).
Silkworth, W. T., Nardi, I. K., Scholl, L. M. & Cimini, D. Multipolar spindle pole coalescence is a major source of kinetochore mis-attachment and chromosome mis-segregation in cancer cells. PLOS ONE 4, e6564 (2009).
Storchova, Z. & Pellman, D. From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell Biol. 5, 45–54 (2004).
Pfau, S. J. & Amon, A. Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Rep. 13, 515–527 (2012).
Zasadil, L. M., Britigan, E. M. & Weaver, B. A. 2n or not 2n: aneuploidy, polyploidy and chromosomal instability in primary and tumor cells. Semin. Cell Dev. Biol. 24, 370–379 (2013).
Silk, A. D. et al. Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors. Proc. Natl Acad. Sci. USA 110, E4134–E4141 (2013).
Kishi, K., Sasaki, T., Kuroda, S., Itoh, T. & Takai, Y. Regulation of cytoplasmic division of Xenopus embryo by rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI). J. Cell Biol. 120, 1187–1195 (1993).
Petronczki, M., Glotzer, M., Kraut, N. & Peters, J. M. Polo-like kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle. Dev. Cell 12, 713–725 (2007). This study nicely shows how spatiotemporal control of furrow ingression is mediated through PLK1.
Kim, J. E., Billadeau, D. D. & Chen, J. The tandem BRCT domains of Ect2 are required for both negative and positive regulation of Ect2 in cytokinesis. J. Biol. Chem. 280, 5733–5739 (2005).
Kosako, H. et al. Rho-kinase/ROCK is involved in cytokinesis through the phosphorylation of myosin light chain and not ezrin/radixin/moesin proteins at the cleavage furrow. Oncogene 19, 6059–6064 (2000).
Kitagawa, M. & Lee, S. H. The chromosomal passenger complex (CPC) as a key orchestrator of orderly mitotic exit and cytokinesis. Front. Cell Dev. Biol. 3, 14 (2015).
Kitagawa, M., Fung, S. Y., Onishi, N., Saya, H. & Lee, S. H. Targeting Aurora B to the equatorial cortex by MKlp2 is required for cytokinesis. PLOS ONE 8, e64826 (2013).
Mollinari, C. et al. Ablation of PRC1 by small interfering RNA demonstrates that cytokinetic abscission requires a central spindle bundle in mammalian cells, whereas completion of furrowing does not. Mol. Biol. Cell 16, 1043–1055 (2005).
Lacroix, B. & Maddox, A. S. Cytokinesis, ploidy and aneuploidy. J. Pathol. 226, 338–351 (2012).
Wong, C. & Stearns, T. Mammalian cells lack checkpoints for tetraploidy, aberrant centrosome number, and cytokinesis failure. BMC Cell Biol. 6, 6 (2005).
Shi, Q. & King, R. W. Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature 437, 1038–1042 (2005).
Thomas, P. et al. Buccal micronucleus cytome assay. Nat. Protoc. 4, 825–837 (2009).
Ramirez, A. & Saldanha, P. H. Micronucleus investigation of alcoholic patients with oral carcinomas. Genet. Mol. Res. 1, 246–260 (2002). This study shows that there is a high percentage of binucleated cells in oral mucosa, suggesting that cytokinesis failures may be common in the human body or at least in this particular tissue.
Nersesyan, A., Kundi, M., Atefie, K., Schulte-Hermann, R. & Knasmuller, S. Effect of staining procedures on the results of micronucleus assays with exfoliated oral mucosa cells. Cancer Epidemiol. Biomarkers Prev. 15, 1835–1840 (2006).
Celik, A. & Kanik, A. Genotoxicity of occupational exposure to wood dust: micronucleus frequency and nuclear changes in exfoliated buccal mucosa cells. Environ. Mol. Mutag. 47, 693–698 (2006).
Celik, A., Yildirim, S., Ekinci, S. Y. & Tasdelen, B. Bio-monitoring for the genotoxic assessment in road construction workers as determined by the buccal micronucleus cytome assay. Ecotoxicol. Environ. Saf. 92, 265–270 (2013).
Duncan, A. W. et al. Frequent aneuploidy among normal human hepatocytes. Gastroenterology 142, 25–28 (2012).
Duncan, A. W. et al. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 467, 707–710 (2010).
Kudryavtsev, B. N., Kudryavtseva, M. V., Sakuta, G. A. & Stein, G. I. Human hepatocyte polyploidization kinetics in the course of life cycle. Virchows Arch. B 64, 387–393 (1993).
Wang, M. J., Chen, F., Lau, J. T. Y. & Hu, Y. P. Hepatocyte polyploidization and its association with pathophysiological processes. Cell Death Dis. 8, e2805 (2017).
Guidotti, J. E. et al. Liver cell polyploidization: a pivotal role for binuclear hepatocytes. J. Biol. Chem. 278, 19095–19101 (2003).
Margall-Ducos, G., Celton-Morizur, S., Couton, D., Bregerie, O. & Desdouets, C. Liver tetraploidization is controlled by a new process of incomplete cytokinesis. J. Cell Sci. 120, 3633–3639 (2007).
Jensen, C. G., Jensen, L. C., Rieder, C. L., Cole, R. W. & Ault, J. G. Long crocidolite asbestos fibers cause polyploidy by sterically blocking cytokinesis. Carcinogenesis 17, 2013–2021 (1996). This study provides evidence that asbestos can promote tumorigenesis by induction of cytokinesis failure.
Overholtzer, M. et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 131, 966–979 (2007). This paper describes the discovery of entosis.
Krajcovic, M. et al. A non-genetic route to aneuploidy in human cancers. Nat. Cell Biol. 13, 324–330 (2011).
Mullins, J. M. & Biesele, J. J. Terminal phase of cytokinesis in D-98s cells. J. Cell Biol. 73, 672–684 (1977).
Norden, C. et al. The NoCut pathway links completion of cytokinesis to spindle midzone function to prevent chromosome breakage. Cell 125, 85–98 (2006).
Steigemann, P. et al. Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell 136, 473–484 (2009).
Mierzwa, B. & Gerlich, D. W. Cytokinetic abscission: molecular mechanisms and temporal control. Dev. Cell 31, 525–538 (2014).
Ichijima, Y. et al. DNA lesions induced by replication stress trigger mitotic aberration and tetraploidy development. PLOS ONE 5, e8821 (2010).
Chan, Y. W., Fugger, K. & West, S. C. Unresolved recombination intermediates lead to ultra-fine anaphase bridges, chromosome breaks and aberrations. Nat. Cell Biol. 20, 92–103 (2018). This study describes the discovery of a distinct class of ultrafine DNA bridges (UFBs), namely, homologous recombination UFBs, that are converted into chromosome fusions when cytokinesis proceeds before they have been resolved.
Germann, S. M. et al. TopBP1/Dpb11 binds DNA anaphase bridges to prevent genome instability. J. Cell Biol. 204, 45–59 (2014).
Caldwell, C. M., Green, R. A. & Kaplan, K. B. APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice. J. Cell Biol. 178, 1109–1120 (2007).
Daniels, M. J., Wang, Y., Lee, M. & Venkitaraman, A. R. Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science 306, 876–879 (2004).
Sinha, S. et al. Von Hippel-Lindau gene product directs cytokinesis: a new tumor suppressor function. J. Cell Sci. 124, 2132–2142 (2011).
Yang, X. et al. LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1. Nat. Cell Biol. 6, 609–617 (2004).
St John, M. A. et al. Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat. Genet. 21, 182–186 (1999).
Sharif, A. A. D. & Hergovich, A. The NDR/LATS protein kinases in immunology and cancer biology. Semin. Cancer Biol. 48, 104–114 (2018).
Fields, A. P. & Justilien, V. The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancer. Adv. Enzyme Regul. 50, 190–200 (2010).
Normand, G. & King, R. W. Understanding cytokinesis failure. Adv. Exp. Med. Biol. 676, 27–55 (2010).
Justilien, V. & Fields, A. P. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Oncogene 28, 3597–3607 (2009).
Miki, T., Smith, C. L., Long, J. E., Eva, A. & Fleming, T. P. Oncogene ect2 is related to regulators of small GTP-binding proteins. Nature 362, 462–465 (1993).
Saito, S. et al. Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation. J. Biol. Chem. 279, 7169–7179 (2004).
Hirata, D. et al. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression. Clin. Cancer Res. 15, 256–266 (2009).
Luo, Y. et al. Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer. Biomed. Pharmacother. 73, 135–139 (2015).
Salhia, B. et al. The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma. Am. J. Pathol. 173, 1828–1838 (2008).
Sano, M. et al. Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients. Oncol. Rep. 16, 1093–1098 (2006).
Chalamalasetty, R. B., Hummer, S., Nigg, E. A. & Sillje, H. H. Influence of human Ect2 depletion and overexpression on cleavage furrow formation and abscission. J. Cell Sci. 119, 3008–3019 (2006).
Canevascini, S., Marti, M., Frohli, E. & Hajnal, A. The Caenorhabditis elegans homologue of the proto-oncogene ect-2 positively regulates RAS signalling during vulval development. EMBO Rep. 6, 1169–1175 (2005).
Justilien, V. et al. Ect2-dependent rRNA synthesis is required for KRAS-TRP53-driven lung adenocarcinoma. Cancer Cell 31, 256–269 (2017).
Gruneberg, U., Neef, R., Honda, R., Nigg, E. A. & Barr, F. A. Relocation of Aurora B from centromeres to the central spindle at the metaphase to anaphase transition requires MKlp2. J. Cell Biol. 166, 167–172 (2004).
Mollinari, C. et al. PRC1 is a microtubule binding and bundling protein essential to maintain the mitotic spindle midzone. J. Cell Biol. 157, 1175–1186 (2002).
Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N. & Szallasi, Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38, 1043–1048 (2006).
Li, J., Dallmayer, M., Kirchner, T., Musa, J. & Grunewald, T. G. P. PRC1: linking cytokinesis, chromosomal instability, and cancer evolution. Trends Cancer 4, 59–73 (2018).
Chen, J. et al. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/beta-catenin signalling pathway. Gut 65, 1522–1534 (2016).
Li, C., Lin, M. & Liu, J. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis. Oncogene 23, 9336–9347 (2004).
Tarapore, P. & Fukasawa, K. Loss of p53 and centrosome hyperamplification. Oncogene 21, 6234–6240 (2002).
Zhan, P. et al. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/beta-catenin signaling pathway. Mol. Cancer 16, 108 (2017).
Claerhout, S. et al. Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer. PLOS ONE 6, e24662 (2011).
Ho, J. R. et al. Deregulation of Rab and Rab effector genes in bladder cancer. PLOS ONE 7, e39469 (2012).
Imai, K. et al. Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer. Br. J. Cancer 104, 300–307 (2011).
Tomita, Y. et al. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T cell epitopes: KIF20A-specific CD4+ T cell immunity in patients with malignant tumor. Clin. Cancer Res. 19, 4508–4520 (2013).
Gasnereau, I. et al. KIF20A mRNA and its product MKlp2 are increased during hepatocyte proliferation and hepatocarcinogenesis. Am. J. Pathol. 180, 131–140 (2012).
Jiang, W. et al. PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol. Cell 2, 877–885 (1998).
Liot, C. et al. APC(cdh1) mediates degradation of the oncogenic Rho-GEF Ect2 after mitosis. PLOS ONE 6, e23676 (2011).
Lind, G. E. et al. SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis. Oncogene 30, 3967–3978 (2011).
Renvoise, B. et al. SPG20 protein spartin is recruited to midbodies by ESCRT-III protein Ist1 and participates in cytokinesis. Mol. Biol. Cell 21, 3293–3303 (2010).
Renvoise, B., Stadler, J., Singh, R., Bakowska, J. C. & Blackstone, C. Spg20−/− mice reveal multimodal functions for Troyer syndrome protein spartin in lipid droplet maintenance, cytokinesis and BMP signaling. Hum. Mol. Genet. 21, 3604–3618 (2012).
Palomero, T. et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat. Genet. 46, 166–170 (2014).
Sakata-Yanagimoto, M. et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat. Genet. 46, 171–175 (2014).
Yoo, H. Y. et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat. Genet. 46, 371–375 (2014).
Manso, R. et al. The RHOA G17V gene mutation occurs frequently in peripheral T cell lymphoma and is associated with a characteristic molecular signature. Blood 123, 2893–2894 (2014).
Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202–209 (2014).
Kakiuchi, M. et al. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma. Nat. Genet. 46, 583–587 (2014).
Wang, K. et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat. Genet. 46, 573–582 (2014).
Rohde, M. et al. Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols. Genes Chromosomes Cancer 53, 911–916 (2014).
Kataoka, K. & Ogawa, S. Variegated RHOA mutations in human cancers. Exp. Hematol. 44, 1123–1129 (2016).
Zhou, J., Hayakawa, Y., Wang, T. C. & Bass, A. J. RhoA mutations identified in diffuse gastric cancer. Cancer Cell 26, 9–11 (2014).
Sahai, E. & Marshall, C. J. RHO-GTPases and cancer. Nat. Rev. Cancer 2, 133–142 (2002).
Vitale, I., Galluzzi, L., Castedo, M. & Kroemer, G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat. Rev. Mol. Cell Biol. 12, 385–392 (2011).
Gascoigne, K. E. & Taylor, S. S. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14, 111–122 (2008). This paper demonstrates that a mitotic delay induced by spindle poisons either results in mitotic slippage or mitotic cell death. The choice between these two different cell fates, one of which produces a genome-doubling event, is controlled by two competing pathways.
Brito, D. A. & Rieder, C. L. The ability to survive mitosis in the presence of microtubule poisons differs significantly between human nontransformed (RPE-1) and cancer (U2OS, HeLa) cells. Cell. Motil. Cytoskeleton 66, 437–447 (2009).
Orth, J. D. et al. Quantitative live imaging of cancer and normal cells treated with kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate. Mol. Cancer Ther. 7, 3480–3489 (2008).
Shi, J., Orth, J. D. & Mitchison, T. Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5. Cancer Res. 68, 3269–3276 (2008).
Brito, D. A., Yang, Z. & Rieder, C. L. Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied. J. Cell Biol. 182, 623–629 (2008).
Brito, D. A. & Rieder, C. L. Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr. Biol. 16, 1194–1200 (2006).
Gascoigne, K. E. & Taylor, S. S. How do anti-mitotic drugs kill cancer cells? J. Cell Sci. 122, 2579–2585 (2009).
Huang, H. C., Shi, J., Orth, J. D. & Mitchison, T. J. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 16, 347–358 (2009).
Lehman, N. L., Verschuren, E. W., Hsu, J. Y., Cherry, A. M. & Jackson, P. K. Overexpression of the anaphase promoting complex/cyclosome inhibitor Emi1 leads to tetraploidy and genomic instability of p53-deficient cells. Cell Cycle 5, 1569–1573 (2006).
Margottin-Goguet, F. et al. Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 4, 813–826 (2003).
Sotillo, R. et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11, 9–23 (2007).
Hernando, E. et al. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430, 797–802 (2004).
Hsu, J. Y., Reimann, J. D., Sorensen, C. S., Lukas, J. & Jackson, P. K. E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1). Nat. Cell Biol. 4, 358–366 (2002).
Gorbsky, G. J. Cohesion fatigue. Curr. Biol. 23, R986–R988 (2013).
Daum, J. R. et al. Cohesion fatigue induces chromatid separation in cells delayed at metaphase. Curr. Biol. 21, 1018–1024 (2011).
Hengeveld, R. C. C., Vromans, M. J. M., Vleugel, M., Hadders, M. A. & Lens, S. M. A. Inner centromere localization of the CPC maintains centromere cohesion and allows mitotic checkpoint silencing. Nat. Commun. 8, 15542 (2017).
Zhou, L. et al. The N-terminal non-kinase-domain-mediated binding of haspin to Pds5B protects centromeric cohesion in mitosis. Curr. Biol. 27, 992–1004 (2017).
Sapkota, H., Wasiak, E., Daum, J. R. & Gorbsky, G. J. Multiple determinants and consequences of cohesion fatigue in mammalian cells. Mol. Biol. Cell 29, 1811–1824 (2018).
Kim, J. S. et al. Intact cohesion, anaphase, and chromosome segregation in human cells harboring tumor-derived mutations in STAG2. PLOS Genet. 12, e1005865 (2016).
de Lange, J. et al. Defective sister chromatid cohesion is synthetically lethal with impaired APC/C function. Nat. Commun. 6, 8399 (2015).
Boveri, T. Zur Frage der Entstehung maligner Tumoren (G. Fischer, 1914). This paper is a must-read classic on the earliest observations of chromosome segregation errors and their consequences.
Davoli, T. & de Lange, T. The causes and consequences of polyploidy in normal development and cancer. Annu. Rev. Cell Dev. Biol. 27, 585–610 (2011).
Dewhurst, S. M. et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 4, 175–185 (2014). This is a landmark paper on the effect of genome-doubling events on cancer evolution.
Lv, L. et al. Tetraploid cells from cytokinesis failure induce aneuploidy and spontaneous transformation of mouse ovarian surface epithelial cells. Cell Cycle 11, 2864–2875 (2012).
Kuznetsova, A. Y. et al. Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cells. Cell Cycle 14, 2810–2820 (2015).
Borel, F., Lohez, O. D., Lacroix, F. B. & Margolis, R. L. Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells. Proc. Natl Acad. Sci. USA 99, 9819–9824 (2002).
Kwon, M. et al. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev. 22, 2189–2203 (2008).
Quintyne, N. J., Reing, J. E., Hoffelder, D. R., Gollin, S. M. & Saunders, W. S. Spindle multipolarity is prevented by centrosomal clustering. Science 307, 127–129 (2005). This paper provides a suitable explanation for the fact that tumour cells can tolerate centrosome amplifications.
Godinho, S. A. & Pellman, D. Causes and consequences of centrosome abnormalities in cancer. Phil. Trans. R. Soc. B 369, 20130467 (2014).
Shoshani, O. et al. Polyploidization of murine mesenchymal cells is associated with suppression of the long noncoding RNA H19 and reduced tumorigenicity. Cancer Res. 72, 6403–6413 (2012).
Levine, M. S. et al. Centrosome amplification is sufficient to promote spontaneous tumorigenesis in mammals. Dev. Cell 40, 313–322 (2017).
Basto, R. et al. Centrosome amplification can initiate tumorigenesis in flies. Cell 133, 1032–1042 (2008). This paper provides the first direct evidence that centrosome amplification per se can promote tumorigenesis.
Sercin, O. et al. Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis. Nat. Cell Biol. 18, 100–110 (2016).
Vitre, B. et al. Chronic centrosome amplification without tumorigenesis. Proc. Natl Acad. Sci. USA 112, E6321–E6330 (2015).
Janssen, A., van der Burg, M., Szuhai, K., Kops, G. J. & Medema, R. H. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 333, 1895–1898 (2011). This paper describes how missegregating chromosomes can break during cytokinesis, giving rise to non-reciprocal or unbalanced translocations.
Soto, M. et al. p53 prohibits propagation of chromosome segregation errors that produce structural aneuploidies. Cell Rep. 19, 2423–2431 (2017).
Aplan, P. D. Causes of oncogenic chromosomal translocation. Trends Genet. 22, 46–55 (2006).
Crasta, K. et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 482, 53–58 (2012). This paper describes how lagging chromosomes that end up in micronuclei can shatter, possibly giving rise to dramatic chromosome rearrangements.
Liu, S. et al. Nuclear envelope assembly defects link mitotic errors to chromothripsis. Nature 561, 551–555 (2018).
Ly, P. et al. Selective Y centromere inactivation triggers chromosome shattering in micronuclei and repair by non-homologous end joining. Nat. Cell Biol. 19, 68–75 (2017).
Hatch, E. M., Fischer, A. H., Deerinck, T. J. & Hetzer, M. W. Catastrophic nuclear envelope collapse in cancer cell micronuclei. Cell 154, 47–60 (2013).
Zhang, C. Z. et al. Chromothripsis from DNA damage in micronuclei. Nature 522, 179–184 (2015).
Van de Peer, Y., Mizrachi, E. & Marchal, K. The evolutionary significance of polyploidy. Nat. Rev. Genet. 18, 411–424 (2017).
Gerstein, A. C. et al. Polyploid titan cells produce haploid and aneuploid progeny to promote stress adaptation. mBio 6, e01340–15 (2015).
Selmecki, A. M. et al. Polyploidy can drive rapid adaptation in yeast. Nature 519, 349–352 (2015).
Yona, A. H. et al. Chromosomal duplication is a transient evolutionary solution to stress. Proc. Natl Acad. Sci. USA 109, 21010–21015 (2012).
Carter, S. B. Effects of cytochalasins on mammalian cells. Nature 213, 261–264 (1967).
Wright, W. E. & Hayflick, L. Formation of anucleate and multinucleate cells in normal and SV 40 transformed WI-38 by cytochalasin B. Exp. Cell Res. 74, 187–194 (1972).
Cross, S. M. et al. A p53-dependent mouse spindle checkpoint. Science 267, 1353–1356 (1995).
Uetake, Y. & Sluder, G. Cell cycle progression after cleavage failure: mammalian somatic cells do not possess a “tetraploidy checkpoint”. J. Cell Biol. 165, 609–615 (2004).
Coelho, P. A. et al. Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse. Open Biol. 5, 150209 (2015).
Kulukian, A. et al. Epidermal development, growth control, and homeostasis in the face of centrosome amplification. Proc. Natl Acad. Sci. USA 112, E6311–E6320 (2015).
Laffin, J., Fogleman, D. & Lehman, J. M. Correlation of DNA content, p53, T antigen, and V antigen in simian virus 40-infected human diploid cells. Cytometry 10, 205–213 (1989).
Schwartz, D., Goldfinger, N. & Rotter, V. Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes. Oncogene 8, 1487–1494 (1993).
Lanni, J. S. & Jacks, T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 18, 1055–1064 (1998).
Andreassen, P. R., Lohez, O. D., Lacroix, F. B. & Margolis, R. L. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol. Biol. Cell 12, 1315–1328 (2001).
Kuffer, C., Kuznetsova, A. Y. & Storchova, Z. Abnormal mitosis triggers p53-dependent cell cycle arrest in human tetraploid cells. Chromosoma 122, 305–318 (2013).
Hinchcliffe, E. H., Miller, F. J., Cham, M., Khodjakov, A. & Sluder, G. Requirement of a centrosomal activity for cell cycle progression through G1 into S phase. Science 291, 1547–1550 (2001).
Khodjakov, A. & Rieder, C. L. Centrosomes enhance the fidelity of cytokinesis in vertebrates and are required for cell cycle progression. J. Cell Biol. 153, 237–242 (2001). This paper nicely describes how centrosome defects affect the fidelity of cytokinesis and provides the first evidence that a human cell that is generated without a centrosome arrests in G1.
Gromley, A. et al. A novel human protein of the maternal centriole is required for the final stages of cytokinesis and entry into S phase. J. Cell Biol. 161, 535–545 (2003).
Mikule, K. et al. Loss of centrosome integrity induces p38-p53-p21-dependent G1-S arrest. Nat. Cell Biol. 9, 160–170 (2007).
Fong, C. S. et al. 53BP1 and USP28 mediate p53-dependent cell cycle arrest in response to centrosome loss and prolonged mitosis. eLife 5, e16270 (2016).
Lambrus, B. G. et al. A USP28-53BP1-p53-p21 signaling axis arrests growth after centrosome loss or prolonged mitosis. J. Cell Biol. 214, 143–153 (2016).
Meitinger, F. et al. 53BP1 and USP28 mediate p53 activation and G1 arrest after centrosome loss or extended mitotic duration. J. Cell Biol. 214, 155–166 (2016).
Aylon, Y. et al. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 20, 2687–2700 (2006).
McPherson, J. P. et al. Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J. 23, 3677–3688 (2004).
Ganem, N. J. et al. Cytokinesis failure triggers hippo tumor suppressor pathway activation. Cell 158, 833–848 (2014). This paper provides the first description of Hippo pathway activation in response to cytokinesis failure.
Holland, A. J. et al. The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle. Genes Dev. 26, 2684–2689 (2012).
Zhang, S. et al. Hippo signaling suppresses cell ploidy and tumorigenesis through Skp2. Cancer Cell 31, 669–684 (2017).
Waterman-Storer, C. M., Worthylake, R. A., Liu, B. P., Burridge, K. & Salmon, E. D. Microtubule growth activates Rac1 to promote lamellipodial protrusion in fibroblasts. Nat. Cell Biol. 1, 45–50 (1999).
Godinho, S. A. et al. Oncogene-like induction of cellular invasion from centrosome amplification. Nature 510, 167–171 (2014). This study provides direct evidence that centrosome amplification per se is sufficient to introduce properties of oncogenic transformation into an otherwise non-transformed cell.
Yu, F. X. et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780–791 (2012).
Brown, C. R., Doxsey, S. J., White, E. & Welch, W. J. Both viral (adenovirus E1B) and cellular (hsp 70, p53) components interact with centrosomes. J. Cell. Physiol. 160, 47–60 (1994).
Ciciarello, M. et al. p53 displacement from centrosomes and p53-mediated G1 arrest following transient inhibition of the mitotic spindle. J. Biol. Chem. 276, 19205–19213 (2001).
Morris, V. B., Brammall, J., Noble, J. & Reddel, R. p53 localizes to the centrosomes and spindles of mitotic cells in the embryonic chick epiblast, human cell lines, and a human primary culture: an immunofluorescence study. Exp. Cell Res. 256, 122–130 (2000).
Fava, L. L. et al. The PIDDosome activates p53 in response to supernumerary centrosomes. Genes Dev. 31, 34–45 (2017).
Tinel, A. & Tschopp, J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304, 843–846 (2004).
Jahn, S. C. et al. Constitutive Cdk2 activity promotes aneuploidy while altering the spindle assembly and tetraploidy checkpoints. J. Cell Sci. 126, 1207–1217 (2013).
Lohez, O. D., Reynaud, C., Borel, F., Andreassen, P. R. & Margolis, R. L. Arrest of mammalian fibroblasts in G1 in response to actin inhibition is dependent on retinoblastoma pocket proteins but not on p53. J. Cell Biol. 161, 67–77 (2003).
Crockford, A. et al. Cyclin D mediates tolerance of genome-doubling in cancers with functional p53. Ann. Oncol. 28, 149–156 (2017).
Potapova, T. A., Seidel, C. W., Box, A. C., Rancati, G. & Li, R. Transcriptome analysis of tetraploid cells identifies cyclin D2 as a facilitator of adaptation to genome doubling in the presence of p53. Mol. Biol. Cell 27, 3065–3084 (2016).
Roy, A. et al. Uncoupling of the Hippo and Rho pathways allows megakaryocytes to escape the tetraploid checkpoint. Haematologica 101, 1469–1478 (2016).
Rhys, A. D. et al. Loss of E-cadherin provides tolerance to centrosome amplification in epithelial cancer cells. J. Cell Biol. 217, 195–209 (2018).
Tanaka, H. et al. Cytokinetic failure-induced tetraploidy develops into aneuploidy, triggering skin aging in phosphovimentin-deficient mice. J. Biol. Chem. 290, 12984–12998 (2015).
De Santis Puzzonia, M., Gonzalez, L., Ascenzi, S., Cundari, E. & Degrassi, F. Tetraploid cells produced by absence of substrate adhesion during cytokinesis are limited in their proliferation and enter senescence after DNA replication. Cell Cycle 15, 274–282 (2016).
Sadaie, M. et al. Cell-based screen for altered nuclear phenotypes reveals senescence progression in polyploid cells after Aurora kinase B inhibition. Mol. Biol. Cell 26, 2971–2985 (2015).
Panopoulos, A. et al. Failure of cell cleavage induces senescence in tetraploid primary cells. Mol. Biol. Cell 25, 3105–3118 (2014).
Vitale, I., Manic, G., Castedo, M. & Kroemer, G. Caspase 2 in mitotic catastrophe: the terminator of aneuploid and tetraploid cells. Mol. Cell. Oncol. 4, e1299274 (2017).
Lopez-Garcia, C. et al. BCL9L dysfunction impairs caspase-2 expression permitting aneuploidy tolerance in colorectal cancer. Cancer Cell 31, 79–93 (2017).
Pedersen, R. S. et al. Profiling DNA damage response following mitotic perturbations. Nat. Commun. 7, 13887 (2016).
Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786–791 (2013).
Ablasser, A. et al. cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING. Nature 498, 380–384 (2013).
Diner, E. J. et al. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep. 3, 1355–1361 (2013).
Gao, P. et al. Cyclic [G(2′,5′)pA(3′,5′)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 153, 1094–1107 (2013).
Zhang, X. et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol. Cell 51, 226–235 (2013). References 195–199 describe the identification of cGAS as a cytosolic DNA sensor that can promote activation of the innate immune response.
Li, T. & Chen, Z. J. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer. J. Exp. Med. 215, 1287–1299 (2018).
de Oliveira Mann, C. C. & Kranzusch, P. J. cGAS conducts micronuclei DNA surveillance. Trends Cell Biol. 27, 697–698 (2017).
Harding, S. M. et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature 548, 466–470 (2017). This paper demonstrates that cGAS is activated by damaged DNA in micronuclei. It also contains data showing that the activation of cGAS in this way can play a role in the abscopal effect (radiotherapy-induced regression of tumours that lie outside of the radiation field).
Mackenzie, K. J. et al. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature 548, 461–465 (2017). This paper also demonstrates that cGAS is activated by damaged DNA in micronuclei, as well as by DNA in micronuclei formed from lagging chromosomes. It contains data showing that activation of cGAS is associated with rupture of the micronuclei.
Santaguida, S. et al. Chromosome mis-segregation generates cell-cycle-arrested cells with complex karyotypes that are eliminated by the immune system. Dev. Cell 41, 638–651 (2017). This paper demonstrates that the acquisition of an aneuploid karyotype triggers activation of an innate immune response.
Bakhoum, S. F. et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553, 467–472 (2018). This paper provides evidence that activation of the cGAS–STING pathway, induced by chromosome segregation errors, can promote cancer cell invasion and metastasis.
Davoli, T., Uno, H., Wooten, E. C. & Elledge, S. J. Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science 355, eaaf8399 (2017). This study analyses 12 different human cancer types and demonstrates that highly aneuploid tumours display a reduction in infiltrating cytotoxic T cells, implying that aneuploidy does not stimulate an antitumour immune response.
McKenzie, C. & D’Avino, P. P. Investigating cytokinesis failure as a strategy in cancer therapy. Oncotarget 7, 87323–87341 (2016).
Wutz, A. Haploid animal cells. Development 141, 1423–1426 (2014).
Pera, F. & Rainer, B. Studies of multipolar mitoses in euploid tissue cultures. I. Somatic reduction to exactly haploid and triploid chromosome sets. Chromosoma 42, 71–86 (1973).
Carlton, J. G., Caballe, A., Agromayor, M., Kloc, M. & Martin-Serrano, J. ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. Science 336, 220–225 (2012).
Cuylen, S., Metz, J., Hruby, A. & Haering, C. H. Entrapment of chromosomes by condensin rings prevents their breakage during cytokinesis. Dev. Cell 27, 469–478 (2013).
Dandoulaki, M., Petsalaki, E., Sumpton, D., Zanivan, S. & Zachos, G. Src activation by Chk1 promotes actin patch formation and prevents chromatin bridge breakage in cytokinesis. J. Cell Biol. 217, 3071–3089 (2018).
Thompson, S. L. & Compton, D. A. Chromosome missegregation in human cells arises through specific types of kinetochore-microtubule attachment errors. Proc. Natl Acad. Sci. USA 108, 17974–17978 (2011).
van Heesbeen, R. G., Tanenbaum, M. E. & Medema, R. H. Balanced activity of three mitotic motors is required for bipolar spindle assembly and chromosome segregation. Cell Rep. 8, 948–956 (2014).
Lingle, W. L., Lukasiewicz, K. & Salisbury, J. L. Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer. Adv. Exp. Med. Biol. 570, 393–421 (2005).
Maiato, H. & Logarinho, E. Mitotic spindle multipolarity without centrosome amplification. Nat. Cell Biol. 16, 386–394 (2014).
Walczak, C. E. & Heald, R. Mechanisms of mitotic spindle assembly and function. Int. Rev. Cytol. 265, 111–158 (2008).
Ertych, N. et al. Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells. Nat. Cell Biol. 16, 779–791 (2014).
Meraldi, P., Honda, R. & Nigg, E. A. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53−/− cells. EMBO J. 21, 483–492 (2002).
Stimpson, K. M., Matheny, J. E. & Sullivan, B. A. Dicentric chromosomes: unique models to study centromere function and inactivation. Chromosome Res. 20, 595–605 (2012).
Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641–645 (2000).
van Steensel, B., Smogorzewska, A. & de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell 92, 401–413 (1998).
Mankouri, H. W., Huttner, D. & Hickson, I. D. How unfinished business from S-phase affects mitosis and beyond. EMBO J. 32, 2661–2671 (2013).
Chan, K. L., Palmai-Pallag, T., Ying, S. & Hickson, I. D. Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nat. Cell Biol. 11, 753–760 (2009).
Naim, V. & Rosselli, F. The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nat. Cell Biol. 11, 761–768 (2009).
Ying, S. et al. MUS81 promotes common fragile site expression. Nat. Cell Biol. 15, 1001–1007 (2013).
Sundin, O. & Varshavsky, A. Terminal stages of SV40 DNA replication proceed via multiply intertwined catenated dimers. Cell 21, 103–114 (1980).
Spence, J. M. et al. Depletion of topoisomerase IIalpha leads to shortening of the metaphase interkinetochore distance and abnormal persistence of PICH-coated anaphase threads. J. Cell Sci. 120, 3952–3964 (2007).
Baumann, C., Korner, R., Hofmann, K. & Nigg, E. A. PICH, a centromere-associated SNF2 family ATPase, is regulated by Plk1 and required for the spindle checkpoint. Cell 128, 101–114 (2007).
Hengeveld, R. C. et al. Rif1 is required for resolution of ultrafine DNA bridges in anaphase to ensure genomic stability. Dev. Cell 34, 466–474 (2015).
Usui, T. et al. Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor, K-252a. J. Cell Biol. 115, 1275–1282 (1991).
Dahmann, C., Diffley, J. F. & Nasmyth, K. A. S-phase-promoting cyclin-dependent kinases prevent re-replication by inhibiting the transition of replication origins to a pre-replicative state. Curr. Biol. 5, 1257–1269 (1995).
Bates, S., Ryan, K. M., Phillips, A. C. & Vousden, K. H. Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression. Oncogene 17, 1691–1703 (1998).
Niculescu, A. B. III et al. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18, 629–643 (1998).
Davoli, T., Denchi, E. L. & de Lange, T. Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 141, 81–93 (2010). This paper shows that telomere dysfunction readily induces tetraploidization by inducing a prolonged G2 arrest, from which cells escape by bypassing mitosis. This implies that genome-doubling events can also arise from (transient) telomere-specific defects.
Bunz, F. et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497–1501 (1998).
Waldman, T., Lengauer, C., Kinzler, K. W. & Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713–716 (1996).
Chen, E. H., Grote, E., Mohler, W. & Vignery, A. Cell-cell fusion. FEBS Lett. 581, 2181–2193 (2007).
De Baetselier, P. et al. Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells. Cancer Metastasis Rev. 3, 5–24 (1984).
Duelli, D. & Lazebnik, Y. Cell fusion: a hidden enemy? Cancer Cell 3, 445–448 (2003).
Ogle, B. M., Cascalho, M. & Platt, J. L. Biological implications of cell fusion. Nat. Rev. Mol. Cell Biol. 6, 567–575 (2005).
Gao, P. & Zheng, J. Oncogenic virus-mediated cell fusion: new insights into initiation and progression of oncogenic viruses-related cancers. Cancer Lett. 303, 1–8 (2011).
Fededa, J. P. & Gerlich, D. W. Molecular control of animal cell cytokinesis. Nat. Cell Biol. 14, 440–447 (2012).
Glotzer, M. The 3Ms of central spindle assembly: microtubules, motors and MAPs. Nat. Rev. Mol. Cell Biol. 10, 9–20 (2009).
Choudhary, A. et al. Interphase cytofission maintains genomic integrity of human cells after failed cytokinesis. Proc. Natl Acad. Sci. USA 110, 13026–13031 (2013).
Bartsch, K. et al. Absence of RNase H2 triggers generation of immunogenic micronuclei removed by autophagy. Hum. Mol. Genet. 26, 3960–3972 (2017).
Acknowledgements
The authors thank the reviewers for their constructive suggestions for improvement. The authors apologize to all of their colleagues whose work could not be cited in this Review because of space limitations. This work is part of Oncode Institute, which is partly financed by the Dutch Cancer Society.
Reviewer information
Nature Reviews Cancer thanks M. Burkard, A. Holland and the other anonymous reviewer for their contribution to the peer review of this work.
Author information
Authors and Affiliations
Contributions
S.M.A.L. and R.H.M. contributed equally to writing the article and to review and editing of the manuscript before submission.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
cBioPortal: http://www.cbioportal.org/
NCI Cancer Genome Anatomy Project: https://cgap.nci.nih.gov/Chromosomes/Mitelman
Supplementary information
Glossary
- Ploidy
-
The number of chromosomes in the nucleus of a cell.
- Tetraploid cell
-
A cell that has four copies of each chromosome (4N).
- Aneuploid cells
-
Cells with an abnormal chromosome content (a number that deviates from a multiple of the haploid (N) set). It encompasses both numerical aneuploidies (gains and/or losses of whole chromosomes) and structural aneuploidies (gains or losses of chromosome segments, including imbalanced translocations).
- Chromosomal instability
-
(CIN). An elevated frequency of chromosome segregation errors during mitosis.
- Centrosomes
-
Organelles consisting of two centrioles and surrounding pericentriolar material that serves as the main microtubule-nucleating and organizing centre of mammalian cells.
- Chromosomal passenger complex
-
(CPC). A protein complex consisting of the mitotic kinase Aurora B, and three non-enzymatic subunits: INCENP, borealin and survivin. It has a dynamic localization in the dividing cell, localizing to the inner centromere region in late prophase and (pro)metaphase, the central spindle and equatorial cortex in anaphase and the midbody in telophase. The complex is essential for the acquisition of proper chromosome–spindle connections and for proper execution of cytokinesis.
- Buccal micronucleus cytome assay
-
A non-invasive assay using exfoliated buccal cells to quantify the mean frequencies of cells containing aberrant nuclei, such as micronuclei (pieces of DNA that reside outside of the nucleus caused by chromosome breakage or missegregation), binucleation and abnormal chromatin condensation.
- Chromatin bridge
-
A DNA structure that is observed in anaphase when the centromeres of the two sister chromatids are pulled towards opposite spindle poles but the sisters remain connected through, for instance, telomere fusion or regions of incompletely replicated DNA.
- Cohesion fatigue
-
Loss of sister chromatid cohesion before anaphase onset that can occur as a consequence of a prolonged metaphase arrest or as a consequence of defects in the machinery that controls timely establishment and loss of cohesin.
- Sister chromatids
-
The two identical copies of a single replicated chromosome that are kept together by DNA catenation and the cohesin complex from S phase until anaphase.
- Mutator phenotype
-
An increase in mutation rate in cancer cells.
- Dicentric chromosomes
-
Abnormal chromosomes with two centromeres, which are usually formed through the fusion of two chromosome segments.
- Centromeres
-
Specialized regions of the chromosome where the kinetochore is assembled, thereby directing the segregation of the chromosomes.
- DNA catenanes
-
Structures generated from the intertwining of replicated sister strands, which occurs when two converging replication forks meet. DNA catenanes are a normal consequence of DNA replication and are resolved during mitosis.
- Kinetochore
-
A multi-protein complex that assembles on centromeres and serves as the main microtubule binding site of the chromosome. It also acts as a signalling platform for the mitotic checkpoint, which is a surveillance mechanism that prevents anaphase onset until all chromosomes are properly connected to the mitotic spindle.
- Non-reciprocal translocations
-
Transfer of a chromosomal fragment of one chromosome to another non-homologous chromosome.
- Replication stress
-
The slowing or stalling of replication fork progression owing to replication barriers formed by difficult to replicate regions, shortage of ribonucleotides or collisions between active translation and replication.
Rights and permissions
About this article
Cite this article
Lens, S.M.A., Medema, R.H. Cytokinesis defects and cancer. Nat Rev Cancer 19, 32–45 (2019). https://doi.org/10.1038/s41568-018-0084-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41568-018-0084-6
This article is cited by
-
Mcph1, mutated in primary microcephaly, is also crucial for erythropoiesis
EMBO Reports (2024)
-
Methylation of ESCRT-III components regulates the timing of cytokinetic abscission
Nature Communications (2024)
-
Aneuploidy and complex genomic rearrangements in cancer evolution
Nature Cancer (2024)
-
Profilin 1 deficiency drives mitotic defects and reduces genome stability
Communications Biology (2023)
-
Unconventional roles of chromatin remodelers and long non-coding RNAs in cell division
Cellular and Molecular Life Sciences (2023)